Proteomics International Laboratories Ltd (ASX:PIQ) Investor Presentation
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors.
Companies in the News
Health & Pharm General
Perth Implant Dental Studio Debuts New Website for Enhanced Patient Experience
Perth Implant Dental Studio, a leading dental practice in Western Australia, is proud to announce the launch of its new website, designed to provide an enhanced and informative experience for patients seeking dental care.
OSC & Vectara Collaborate on AI Search Engine Relevance Measurement
Vectara, the Trusted Generative AI Product Platform, and OpenSource Connections (OSC), creators of Quepid, collaborate to provide third-party evaluation of search relevance and measurement.
MontaVista Extends Strategic Focus on Embedded Linux Security, Industrial/Robotics Solutions and ROS Support
MontaVista® Software, LLC, a leader in commercial Embedded Linux® products and services, announced it has embarked on a strategic initiative to embed secure platform principles throughout MontaVista’s product lineup to meet the ever increasing cyber security needs of industrial IoT, robotics, medical, and smart infrastructure applications.
Workplace Preparedness Wins: Queensland Tradie's Heartbeat Restored By An AED At Work
The recent ordeal of a 42-year-old workshop operator brought back from the dead at work, underscores the life-saving potential of preparedness in the face of cardiac emergencies.
Proteomics International Laboratories Ltd (ASX:PIQ) September 2023 Quarterly Activities Report
Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 September 2023 and subsequent to the period end.
KALI’S TRIPLE CROWN AS PANACEA NAMED FINALIST FOR 3RD INTERNATIONAL STARTUP OF THE YEAR AT 20TH ANNUAL STEVIE AWARDS
Panacea was named a Finalist in the Startup of the Year category in the 20th annual Stevie® Awards for Women in Business, and ultimately will be a Gold, Silver, or Bronze Stevie Award winner at the event in New York City on November 10, 2023.
◂Previous Page
Health & Pharm General Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
